tiprankstipranks
Trending News
More News >
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
US Market

Sensei Biotherapeutics (SNSE) Income Statement

Compare
222 Followers

Sensei Biotherapeutics Income Statement

Last quarter (Q3 2025), Sensei Biotherapeutics's total revenue was $-4.85M, a decrease of -Infinity% from the same quarter last year. In Q3, Sensei Biotherapeutics's net income was $-4.57M. See Sensei Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -551.00K$ -571.00K$ -1.81M$ -685.00K$ -209.00K
Operating Expenses
$ 31.11M$ 36.49M$ 47.31M$ 36.80M$ 19.24M
Depreciation and Amortization
$ 551.00K$ 3.68M$ 1.81M$ 685.00K$ 209.00K
EBITDA
$ -29.52M$ -33.39M$ -46.56M$ -35.44M$ -18.20M
Operating Income
$ -31.66M$ -37.06M$ -49.12M$ -37.48M$ -19.45M
Other Income/Expenses
$ 1.51M$ 2.96M$ 532.00K$ 688.00K$ -649.00K
Pretax Income
$ -30.16M$ -34.10M$ -48.59M$ -36.79M$ -20.10M
Net Income
$ -30.16M$ -34.10M$ -48.59M$ -36.79M$ -20.10M
Per Share Metrics
Basic EPS
$ -1.20$ -1.22$ -1.58$ -1.33$ -0.67
Diluted EPS
$ -1.20$ -1.22$ -1.58$ -1.33$ -0.67
Weighted Average Shares Outstanding
25.12M 27.95M 30.70M 27.71M 30.59M
Weighted Average Shares Outstanding (Diluted)
25.12M 27.95M 30.70M 27.71M 30.59M
Currency in USD

Sensei Biotherapeutics Earnings and Revenue History